Compare DexCom, Inc. (DXCM) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Consumer Staples Select Sector SPDR Fund — how do they compare? DexCom, Inc. trades at $77.88 (market cap $28.06B), while Consumer Staples Select Sector SPDR Fund trades at $85.72. Which is the better fit depends on your goals.
| DXCM | XLP | |
|---|---|---|
Market Cap | $28.06B | — |
Sector | Health | — |
52-Week High | $89.53 | $90.00 |
52-Week Low | $54.84 | $75.61 |
Enterprise Value | $27.03B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
XLP trades at $85.51, up 2.52% with a bullish analyst consensus of 100% buy ratings. Technical indicators show bearish momentum despite the recent gain, with resistance at $85. The ETF's 2.6% dividend yield provides income appeal amid market volatility, though key valuation ratios remain unavailable for detailed fundamental assessment.
The defensive consumer staples sector positioning offers stability during economic uncertainty, but technical weakness and concentrated holdings present near-term risks. Long-term prospects depend on sector performance and expense ratio competitiveness against peers like VDC.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
